New MRD Assessment Data Using clonoSEQ® To Be Presented at 2024 ASCO Annual Meeting and EHA2024 Hybrid Congress

Read More

100 Publications

Scientists across disease areas continue to propel their research, elucidating the immune response in diseases as varied as multiple sclerosis, metastatic melanoma, and peanut allergy.

A Giant Step Forward in Developing Clinical Diagnostics and Therapeutics

Adaptive develops new technology to map T cells to the antigens they target, providing the capability to see what diseases the immune system responds to and setting the stage for novel diagnostic tests. New technology to pair the chains of T-cell receptors (TCRs) helps identify which ones have the greatest therapeutic potential.